---
title: "Shreeji Dyechem Ltd (531290) — Share Price, Financials & Analysis"
symbol: "531290"
company: "Shreeji Dyechem Ltd"
canonical: "https://tapetide.com/stocks/531290"
bse_code: "531290"
sector: "Commodities"
industry: "Chemicals & Petrochemicals"
generated_at: "2026-09-13T18:26:45.608Z"
---

# Shreeji Dyechem Ltd (531290)

Canonical page: https://tapetide.com/stocks/531290

## Company

- **BSE Code:** 531290
- **Sector:** Commodities
- **Industry:** Chemicals & Petrochemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** shreejidyechem.com

## About

Shreeji Dyechem is primarily engages in manufacturing of Pretreatment Chemicals, FMCG Products, Dyes Intermediates, Finishing Chemicals, Enzymes, Agricultural Chemical For Foliar Application, Chemical Solution For Agriculture and Dispersive Media.

## Latest Price

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- Company has a low return on equity of -1.69% over last 3 years.

## Growth Rates

| Metric | 5Y |
| --- | --- |
| net income growth | 12% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.01 | 0.02 | 0.02 | 0.02 | 0.06 | 0.01 | 0.01 | 0.01 | 0.45 | 0.01 | 0.01 | 0.01 |
| Operating Profit | -0.01 | -0.02 | -0.02 | -0.02 | -0.06 | -0.01 | -0.01 | -0.01 | -0.45 | -0.01 | -0.01 | -0.01 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.4 | 0 | -2.49 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.01 | -0.02 | -0.02 | -0.02 | -0.06 | -0.01 | -0.01 | -0.01 | -0.85 | -0.01 | -2.5 | -0.01 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 215.29 | 0 | 0 | 0 |
| Net Profit | -0.01 | -0.02 | -0.02 | -0.02 | -0.06 | -0.01 | -0.01 | -0.01 | -2.68 | -0.01 | -2.5 | -0.01 |
| EPS in Rs | -0.03 | -0.06 | -0.06 | -0.06 | -0.17 | -0.03 | -0.03 | -0.03 | -7.63 | -0.03 | -7.11 | -0.03 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0.45 | 1.46 | 0.41 | 0 | 0 | 0 |
| Expenses | 0.01 | 0.3 | 0.12 | 1.45 | 0.45 | 0.06 | 0.06 | 0.48 |
| Operating Profit | -0.01 | -0.3 | 0.33 | 0.01 | -0.04 | -0.06 | -0.06 | -0.48 |
| OPM % | — | — | 73.33 | 0.68 | -9.76 | — | — | — |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.89 |
| Interest | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.01 | -0.3 | 0.3 | 0.01 | -0.04 | -0.06 | -0.06 | -3.37 |
| Tax % | 0 | 0 | 0 | 100 | 0 | 0 | 0 | — |
| Net Profit | -0.01 | -0.3 | 0.3 | 0.01 | -0.04 | -0.06 | -0.06 | -5.2 |
| EPS in Rs | -0.03 | -0.85 | 0.85 | 0.03 | -0.11 | -0.17 | -0.17 | -14.8 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 3.39 | 3.39 | 3.39 | 3.39 | 3.39 | 3.39 | 3.39 |
| Reserves | -0.17 | -0.46 | -0.16 | -0.16 | -0.2 | -0.26 | -0.32 |
| Borrowings | 0.86 | 0.77 | 0.49 | 0.25 | 0.25 | 0.25 | 0.25 |
| Other Liabilities | 0.08 | 0.37 | 0.34 | 0.36 | 0.17 | 0.15 | 0.17 |
| Total Liabilities | 4.16 | 4.07 | 4.06 | 3.84 | 3.61 | 3.53 | 3.49 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 4.15 | 4.06 | 4.06 | 3.84 | 3.61 | 3.53 | 3.49 |
| Total Assets | 4.16 | 4.07 | 4.06 | 3.84 | 3.61 | 3.53 | 3.49 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.09 | 0.13 | -0.1 | 0.25 | 0.01 | -0.02 | -0.02 |
| Cash from Investing Activity | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing Activity | -0.09 | -0.13 | 0.11 | -0.24 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0.01 | 0.01 | 0.01 | -0.02 | -0.02 |
| Free Cash Flow | 0.09 | 0.13 | -0.1 | 0.25 | 0.01 | -0.02 | -0.02 |
| CFO/OP | -900 | -43 | -30 | 2500 | -25 | 33 | 33 |

### Ratios

| Item | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | — | — | 389.33 | 137.5 | 427.32 | — | — |
| Inventory Days | — | — | — | 0 | 0 | — | — |
| Cash Conversion Cycle | — | — | 389.33 | 137.5 | 427.32 | — | — |
| Working Capital Days | — | — | 267.67 | 70 | 329.39 | — | — |
| ROCE % | — | -7.71 | 8.89 | 0.28 | -1.16 | -1.76 | -1.79 |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Dec 2017 |
| --- | --- | --- |
| Promoters | 49.57% | 49.57% |
| Public | 50.43% | 50.43% |
| No. of Shareholders | 2622 | 2621 |

### Quarterly

| Category | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 49.57% | 49.57% | 49.57% | 49.57% | 49.57% | 49.57% | 49.57% |
| Public | 50.43% | 50.43% | 50.43% | 50.43% | 50.43% | 50.43% | 50.43% |
| No. of Shareholders | 2622 | 2622 | 2622 | 2622 | 2621 | 2621 | 2621 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Neutral
- **Buy / Neutral / Sell:** 0 / 19 / 0

### Moving Averages — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | — | Neutral |
| EMA (10) | — | Neutral |
| SMA (20) | — | Neutral |
| EMA (20) | — | Neutral |
| SMA (50) | — | Neutral |
| EMA (50) | — | Neutral |
| SMA (100) | — | Neutral |
| EMA (100) | — | Neutral |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | — | Neutral |
| MACD (12,26,9) | — | Neutral |
| Stochastic (14,3,3) | — | Neutral |
| ADX (14) | — | Neutral |
| Williams %R (14) | — | Neutral |
| ATR (14) | — | Neutral |
| ROC (12) | — | Neutral |
| Stoch RSI (14) | — | Neutral |
| UO (7,14,28) | — | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8h - CARE placed IGL’s Rs1,229.79Cr term loan, Rs450Cr working capital, Rs850Cr BG/LC on RWD; demerger cited. | [Announcement under Regulation 30 (LODR)-Credit Rating 8h - CARE placed IGL’s Rs1,229.79Cr term loan, Rs450Cr working capital, Rs850Cr BG/LC on RWD; demerger cited.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/10957c8f-bd8c-4043-abd1-cec6e6edd51e.pdf) |
| 21 Feb - Newspaper publication regarding notice of the Meeting of the Equity Shareholders and Unsecured Creditors as per directions of Hon''ble National Company Law Tribunal, Allahabad Bench, … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 21 Feb - Newspaper publication regarding notice of the Meeting of the Equity Shareholders and Unsecured Creditors as per directions of Hon''ble National Company Law Tribunal, Allahabad Bench, …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9d6b1929-9b5c-49cb-8728-aeceb49cf5c7.pdf) |
| 20 Feb - NCLT‑convened unsecured creditors meeting on 24 March 2026 to approve India Glycols' demerger into Ennature and IGL Spirits. | [Notice Of Meeting Of The Unsecured Creditors Of India Glycols Limited Convened By The Hon''ble National Company Law Tribunal, Allahabad Bench, Prayagraj 20 Feb - NCLT‑convened unsecured creditors meeting on 24 March 2026 to approve India Glycols' demerger into Ennature and IGL Spirits.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/77640e69-7d00-4093-9a4d-4a27146df89f.pdf) |
| 18 Feb - NCLT reschedules India Glycols shareholders and unsecured creditors meetings from 9 March 2026 to 24 March 2026. | [Revised Order - NCLT 18 Feb - NCLT reschedules India Glycols shareholders and unsecured creditors meetings from 9 March 2026 to 24 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8869b63a-7bc2-4371-ac1d-d64493b3e52b.pdf) |
| 12 Feb - Q3 & 9MFY26 earnings conference call audio posted on company website on 12-Feb-2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 12 Feb - Q3 & 9MFY26 earnings conference call audio posted on company website on 12-Feb-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/d885f657-5e6a-48d2-9a34-440ea39eabe1.pdf) |
| 10h - Board meeting on 17 March 2026 to consider interim dividend; trading window closed 11–19 March 2026. | [Board Meeting Intimation for Consider Declaration Of Interim Dividend, If Any, For The Financial Year 2025-26. 10h - Board meeting on 17 March 2026 to consider interim dividend; trading window closed 11–19 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/bbbcc81f-0090-4130-bccd-90ae40e2cf8f.pdf) |
| 10h - Board meeting on 17 March 2026 to consider interim dividend; trading window closed 11–19 March 2026. | [Corporate Action-Board to consider Dividend 10h - Board meeting on 17 March 2026 to consider interim dividend; trading window closed 11–19 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4158773f-ffc1-4186-a663-92c9baa223d8.pdf) |
| 10 Feb - Q3 PAT Rs65.26cr; 9M PAT Rs172.05cr; Rs467cr preferential allotment; NCLT allowed demerger (appointed 1 Apr 2026) | [Board Meeting Outcome for Outcome Of Board Meeting Held On 10Th February, 2026 10 Feb - Q3 PAT Rs65.26cr; 9M PAT Rs172.05cr; Rs467cr preferential allotment; NCLT allowed demerger (appointed 1 Apr 2026)](https://www.bseindia.com/xml-data/corpfiling/AttachLive/5993d2e1-5022-4b43-93d8-accfdae69686.pdf) |
| 10 Feb - Monitoring agency confirms full utilization of Rs.466.99 crore preferential proceeds by Dec 31, 2025. | [Report Of Monitoring Agency On Utilization Of Proceeds Of Preferential Issue. 10 Feb - Monitoring agency confirms full utilization of Rs.466.99 crore preferential proceeds by Dec 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/be9f5abe-fb97-4d62-a19f-70a0e25ef01c.pdf) |
| — | [Notice Of Meeting Of The Equity Shareholders Of India Glycols Limited Convened By The Hon''ble National Company Law Tribunal, Allahabad Bench, Prayagraj. 20 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f32ef67d-5810-4244-a659-9b69f6a299c7.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2c9d5844-41a1-4f6e-9b31-893a125e6567.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7af74fac-28a7-4606-9be7-11c176ebaba8.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/43cf98b1-158d-4aa9-9a57-e8d74c011449.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f2ac16b6-f1ad-4fb3-9516-7623dfab1e65.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d7bb0963-5e2c-4443-8648-6f1213fbf842.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d532715b-c088-4be2-b619-e7a41528d1e7.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/486e665d-6467-4223-95d0-810ed0123aa7.pdf) |
| Jun 2024 | [Concall - Jun 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/47d07394-61eb-4ec4-8e04-35c30855d685.pdf) |
| Jun 2022 | [Concall - Jun 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/850f580d-7565-4982-a95d-585d4be6a173.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/203f7ec9-7aed-4447-a8fd-baa9312eabd6.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2013 from nse](https://archives.nseindia.com/annual_reports/AR_1222_INDIAGLYCO_2012_2013_27082013104733.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7ea40985-c46d-400b-b669-59957d7658ab.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/20671c87-1250-4d68-99c5-5b6258a07de2.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/10fe6551-cf31-4e41-b572-777163d5faa5.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/500201/74310500201.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/500201/70350500201.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/500201/65305500201.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/500201/5002010319.pdf) |
| from bse | [Financial Year 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/500201/5002010318.pdf) |
| from bse | [Financial Year 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/500201/5002010317.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:26:45.608Z.